openPR Logo
Press release

Clinical Trial Management System Industry Size 2018 Study In Detail Along With Growing Factors, by Mode of Delivery, Future Prospects And Trends By Forecast To 2023

04-03-2018 09:43 AM CET | Business, Economy, Finances, Banking & Insurance

Press release from: Market Research Future

Clinical Trial Management System Market

Clinical Trial Management System Market

Clinical Trial Management System Market - Overview

Clinical trial management system are software that are used by pharmaceutical and biotechnological companies for managing clinical trials for research purposes. These system are commissioned to maintain records, reporting, managing the performance, and planning for keeping a track of the process of clinical trials. These management system are able to provide accuracy and sophistication to the information along with managing the rigorous activities conducted under the clinical trials which accounts to be a key driver for the market.

As per the statistics by the U.S. FDA, more than 126,000 clinical trials are conducted with the help of clinical trial management system. For instance, various oncology drugs are routinely administered to patients prior to its approval by the U.S. FDA and is regarded as a part of access trial. Furthermore, increasing innovation of treatment are contributing towards the growth of the clinical trials management systems.

Ask for Sample copy @ https://www.marketresearchfuture.com/sample_request/2054 .

Clinical Trial Management System Market is expected to grow at a CAGR of 12% by the end of the forecasted period.

Clinical Trial Management System Market - Top Players

GCP-Service International Ltd. & Co. KG (Germany)

 PAREXEL International Corporation (U.S.)

 HCL Technologies Limited (US)

  Oracle (US)

 Bioclinica

 Covance Inc.

 eclipse

 Etc.

Industry Updates:

May, 2017 Chiltern International Ltd. announced the acquisition of Integrated Development Associates Co. Ltd. The aim is to strengthen their position within the Asia Pacific region, which is anticipated to be the most lucrative region over the forecast period.

Jan, 2015 Hospira had submitted the review of biosimilar of Epogen (Epoetin Alfa) to the FDA in the U.S. and is awaiting approval within a year.

Clinical trial management system Market - Regional Analysis

The global clinical trial management system market is segmented into five major regions including Americas, Europe, Asia Pacific, and Middle East and Africa region.

Americas dominated the global clinical trial management system market in terms of revenue share owing to the presence of big outsourcing firms and increasing R&D in the region. The North America region conducts the highest number of clinical trials. As per a study conducted by BioOutsource, the increasing demand for testing biosimilars is anticipated to grow in the U.S. This can be attributed to the lack of clear guidance which are being addressed by the U.S. FDA finally revealing the biosimilars. Moreover, specifically to the developers that are trying to prove their drugs similarity to that of the original product.

The European market is the second largest market for clinical trial management system. Management software plays an important role to minimize the cost of clinical trials. These systems are a natural fit for early phase trials, since they are more dynamic and involves scientific work than the later phase of trials. The biomarkers are used to increase the success ratio of the clinical trials and to evaluate the efficiency of its rapid development.

Furthermore, Asia Pacific region has emerged as the fastest growing market for clinical trial management system. The Middle-East and Africa Clinical trial management market has been evaluated as moderately growing market and it is expected that the market will continue to grow at same pace in the near future. Clinical trial is major process in drug development process. Drug development process is expensive and need huge funding. Imaging perform different function in clinical trials like detection, characterization, and monitoring or assessment. Pharmaceutical and biotechnology companies investing in R&D to develop new drugs which further observed and make available to the public. Increasing number of non-communicable diseases, improved healthcare infrastructure, and government initiatives are leading the growth for clinical trial management market in Middle East and Africa.

Global Clinical trial management system Market – Competitive Analysis

The key strategic adopted by in the market players are regional expansion, collaboration and merger & acquisitions and others. For instance, Pfizer operates with three CROs to enhance its product portfolio and conduct new R&D. Moreover in 2011, Pfizer entered into partnership agreement with ICON. The company preserves the scientific ownership for the studies and trials conducted by ICON, thereby allowing Pfizer to develop its capabilities in designing clinical trial.

Check Discount @ https://www.marketresearchfuture.com/check-discount/2054 .

Top 5 Reasons to Purchase this Report:

Company profiling with detailed strategies, financials, and recent development activities.

Market Strategic Business Influence Data.

Market Research Future recommendations in key business segments based on the market estimations.

Market share analysis of the top industry players.

Market forecasts for a minimum of 5 years of all the mentioned segments, Trends and the regional markets With SWOT Analysis.

Major TOC:

1 Introduction

1.1 Definition

1.2 Scope Of Study

1.3 Research Objective

1.4 Assumptions & Limitations

1.5 Market Structure:

2 Research Methodology

2.1 Research Process

2.2 Primary Research

2.3 Secondary Research

3 Market Dynamics

3.1 Drivers

3.2 Restraints

3.3 Opportunities

3.4 Challenges

3.5 Macroeconomic Indicators

4 Market Factor Analysis

And more…

Have any Query Regarding the Clinical Trial Management System Market Report, Ask to our Expert @ https://www.marketresearchfuture.com/enquiry/2054 .

About Market Research Future:

At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.

Contact

Market Research Future

Office No. 528, Amanora Chambers

Magarpatta Road, Hadapsar,

Pune – 411028

Maharashtra, India

+1 646 845 9312

Email: sales@marketresearchfuture.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Clinical Trial Management System Industry Size 2018 Study In Detail Along With Growing Factors, by Mode of Delivery, Future Prospects And Trends By Forecast To 2023 here

News-ID: 1001174 • Views:

More Releases from Market Research Future

Hydrofluoric Acid Market (CAGR) of 4%, Innovation Imperative Future Proofing Your Business with Market Size
Hydrofluoric Acid Market (CAGR) of 4%, Innovation Imperative Future Proofing You …
Hydrofluoric acid (HF) is a crucial chemical compound with a wide range of applications across various industries. Despite its hazardous nature, it plays an essential role in manufacturing processes, especially in the production of fluorine compounds. The global hydrofluoric acid market has been witnessing steady growth, driven by demand from end-user industries such as oil refining, pharmaceuticals, and electronics. The Hydrodesulfurization Catalysts Market is projected to register a CAGR of over
Palm Methyl Ester Derivative Market Size Projected to Grow at 5.92% CAGR, Reaching USD 2.4 billion by 2030
Palm Methyl Ester Derivative Market Size Projected to Grow at 5.92% CAGR, Reachi …
In recent years, the global market for palm methyl ester derivatives has witnessed significant growth, driven by various factors including environmental concerns, technological advancements, and the increasing demand for sustainable alternatives in various industries. Palm methyl ester derivatives, derived from palm oil, have emerged as versatile ingredients with applications spanning across sectors such as cosmetics, pharmaceuticals, lubricants, and more. The Palm Methyl Ester Derivative Market Size was valued at USD 1.5
Asia-Pacific Ceramic Tiles Market to Register Highest CAGR Growth of 7.50% by 2032: Analysis by Segmentation, Competitors Analysis
Asia-Pacific Ceramic Tiles Market to Register Highest CAGR Growth of 7.50% by 20 …
The Asia-Pacific ceramic tiles market has been witnessing robust growth, driven by various factors such as increasing investments in residential and commercial construction, renovation activities, and the growing preference for aesthetically pleasing and durable flooring solutions. Countries like China, India, Japan, and South Korea have been leading the market growth, supported by strong manufacturing capabilities, technological advancements, and evolving consumer preferences. Asia-Pacific Ceramic Tiles Market Size was valued at USD 141.2
APAC Wallpaper Market to Register Highest CAGR Growth of 8% by 2032: Analysis by Segmentation, Competitors Analysis
APAC Wallpaper Market to Register Highest CAGR Growth of 8% by 2032: Analysis by …
The APAC wallpaper market has witnessed significant growth in recent years, driven by factors such as rising disposable incomes, expanding construction activities, and growing awareness regarding interior decor. Countries like China, India, Japan, South Korea, and Australia have emerged as key contributors to the region's wallpaper market. Additionally, the increasing adoption of innovative wallpaper designs and patterns is fueling market growth further. APAC Wallpaper Market Size was valued at USD 0.55

All 5 Releases


More Releases for Clinical

Clinical Laboratory Market in Indonesia, Clinical Laboratory Industry in Indones …
"Increase in healthcare expenditure from the Indonesian government has driven the growth of clinical laboratory market in Indonesia." Increase in Healthcare Awareness: Largely driven by increase in healthcare spending by aging population (~$ 260 per person by 2050), rising income levels, rising awareness for preventive testing, advanced healthcare diagnostic tests offerings, and central government's healthcare measures. Developments in Testing and Preference for Evidence based testing: There is also a rising number
Clinical solutions
Are you spending more time with yellow files than with patients? Healthbridge can change that with our intuitive and easy to use clinical platform that is designed specifically for the medical practitioner at the practice. smaller2 Easily access patient information Cloud-based technology enables you to store rich clinical information that can be easily accessed as and when you need it. Medical billing software innovation Become a paperless practice Create scripts, sick notes, and clinical notes electronically. Plus, have
Clinical Research and Clinical Trials Summit
Clinical Research 2019 has been designed in an interdisciplinary manner with a multitude of tracks to choose from every segment and provides you with a unique opportunity to meet up with peers from both industry and academia and establish a scientific network between them. We cordially invite all concerned people to come join us at our event and make it successful by your participation. This is the premier interdisciplinary forum for
Paediatric Clinical Trial Conference - When designing a Paediatric clinical tria …
Press Release – 12.02.2018 When designing a Paediatric clinical trial, a paediatric investigation plan (PIP) is a development plan aimed at ensuring that the necessary data are obtained through studies in children, to support the authorisation of a medicine for children. All applications for marketing authorisation for new medicines have to include the results of studies as described in an agreed PIP, unless the medicine is exempt because of a deferral
Clinical Communication
According to a recent market report published by Persistence Market Research titled “Clinical Communication and Collaboration Market: Global Industry Analysis (2012–2016) and Forecast (2017–2025),” revenue from the global clinical communication and collaboration market was US$ 138.5 Mn in 2012 and US$ 214.8 Mn in 2016, representing a CAGR of 11.6% from 2012 to 2016. This revenue growth is attributed to addition of new features in clinical communication and collaboration solutions.
E-Clinical Trial Solutions Market To Accelerating Clinical Development Technolog …
The study of the "Global e-Clinical Trial Solutions Market" provides the market size information and market trends along with the factors and parameters impacting it in both short and long term. The study ensures a 360° view, bringing out the complete key insights of the industry. The Global e-Clinical Trial Solutions Market Research Report Forecast 2017-2021 is a valuable source of insightful data for business strategists. It provides the e-Clinical